{
    "SPADE_UN_21762": {
        "Sequence Information": {
            "Peptide Name": "LL-37 (17-29)",
            "Sequence": "FKRIVQRIKDFLR",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiviral",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer\n2. Virus replication",
            "Source": "",
            "Gene": "",
            "PDB ID": "6S6M",
            "UniProt Entry": [
                {
                    "uniprotId": "P49913",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P49913",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins",
                    "Pubmed ID": "18591279",
                    "Reference": "Antimicrob Agents Chemother. 2008;52:3438–3440",
                    "Author": "Wang G, Watson KM, Buckheit RW Jr",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18591279"
                },
                {
                    "Title": "Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus.",
                    "Pubmed ID": "30120393",
                    "Reference": "J Antibiot (Tokyo). 2018;71:971-974",
                    "Author": "Shurko JF, Galega RS, Li C, Lee GC",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30120393"
                },
                {
                    "Title": "Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa.",
                    "Pubmed ID": "31608030",
                    "Reference": "Front Microbiol. 2019;10:2190",
                    "Author": "Mohammed I, Said DG, Nubile M, Mastropasqua L, Dua HS",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31608030"
                },
                {
                    "Title": "Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.",
                    "Pubmed ID": "23894079",
                    "Reference": "ChemMedChem. 2013;8:1638-1642",
                    "Author": "Son M, Lee Y, Hwang H, Hyun S, Yu J",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23894079"
                },
                {
                    "Title": "Rare by Natural Selection: Tunable Disulfide-bonded Supramolecular Antimicrobials Peptides",
                    "Pubmed ID": "",
                    "Reference": "Research Square. 2021;DOI: 10.21203/rs.3.rs-578319/v1:",
                    "Author": "Engelberg Y, Ragonis-Bachar P, Landau M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                }
            ],
            "Mass": 1719.08,
            "PI": 11.72,
            "Net Charge": 4,
            "Hydrophobicity": -0.44,
            "Frequent Amino Acids": "RFI",
            "Absent Amino Acids": "ACEGHMNOPSTUWY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 6,
            "Polar Residues": 7,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_UN_21762",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02277",
                    "Similarity": 1.0,
                    "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"
                },
                {
                    "SPADE_ID": "SPADE_N_02334",
                    "Similarity": 1.0,
                    "Sequence": "LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES"
                },
                {
                    "SPADE_ID": "SPADE_N_03100",
                    "Similarity": 1.0,
                    "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"
                }
            ],
            "Hemolytic Activity": "CEM-SS cells:50% cell death=10.4 µM,Human corneal epithelial cells HCE-2:EC50=>200 µg/ml,Human erythrocytes:10% Hemolysis=160 µM",
            "Target Organism": "HIV(IC50 REP=3.4µM),Staphylococcus aureus ATCC 25923(MIC=512µg/ml),Staphylococcus aureus ATCC 43300(MIC=256µg/ml),Staphylococcus aureus ATCC 700699(MIC=1024µg/ml),Staphylococcus aureus(MIC=512µg/ml),Pseudomonas aeruginosa PAO1(MIC=28.14µM),Pseudomonas aeruginosa PAO1(MIC=116.28µM),Pseudomonas aeruginosa ATCC 19660(MIC=116.28µM),Pseudomonas aeruginosa ATCC 19660(MIC=>116.28µM),Pseudomonas aeruginosa(MIC=116.28µM),Pseudomonas aeruginosa(MIC=>116.28µM),Pseudomonas aeruginosa PAO1(IC50=49.3±2.2µg/ml),Pseudomonas aeruginosa ATCC 19660(IC50=89.5±6.1µg/ml),Pseudomonas aeruginosa(IC50=91.5±8.1µg/ml),Escherichia coli ATCC 25922(MIC=5µM),Staphylococcus aureus ATCC 29213(MIC=40µM),Micrococcus luteus(MIC=25±2µM),Staphylococcus hominis ATCC 27844(MIC=39±1µM),Escherichia coli K3 3106(MIC=47±3µM),Pseudomonas fluorescens(MIC=136±4µM)"
        }
    }
}